Atherosclerosis Biomarkers Among Egyptian Patients with Systemic Lupus Erythematosus: Population Based Study

Journal Title: Immunological Disorders and Immunotherapy - Year 2018, Vol 3, Issue 1

Abstract

Systemic lupus erythematosus is associated with increased risk of atherosclerosis; endothelial dysfunction is believed one of the most important initial steps of the atherosclerosis process. The aim of this study is to evaluate endothelial microparticles (EMPs) (VCAM-1/CD105) in addition to Carotid intima-media thickness (cIMT), as biomarkers of atherosclerosis, among Egyptian Systemic lupus erythematosus (SLE) patients and its correlation to SLE related risk factors. We compared data obtained from 60 Egyptian SLE patients neither of them had diabetes, hypertension nor smokers, with 30, age and sex matched healthy volunteers. Both patients and controls were subjected to full history taking and clinical examination as well as basic laboratory investigations in addition to VCAM-1 ELISA, CD105 by flow cytometer and Carotid arteries ultrasound to assess intima-media thickness and the presence of plaques. Our results revealed highly significant increase of cIMT, CD105, VCAM-1, total cholesterol and LDL-cholesterol in SLE patients compared to normal controls (P <0.001). In comparing SLE patients with increased cIMT with those with normal cIMT, we found significant increase in LDL cholesterol, steroid duration and highly significant increase of steroid cumulative dose and disease duration. Also, SLE patients with positive anti-dsDNA showed significant increase in cIMT (P<0.05) in comparison to anti-dsDNA negative patients at the time of sampling. Our results also demonstrated no correlation between Anti-Cardiolipin antibodies (ACL) and cIMT, VCAM-1 or CD105. We found that SLE patients had a significant increase in cIMT, VCAM-1 and CD105 compared with the controls. This significant increase in these atherosclerotic biomarkers was not correlated with indices of disease activity or presence of anti-dsDNA or ACL antibodies but correlated with disease and steroid duration, steroid cumulative dose, age and LDL-C level.

Authors and Affiliations

El-Desouki Fouda, Mahmoud Eid, Mona Hilmy Al-Rayes, Mokhtar Ragab and Gamal Abdelghany Khalifa

Keywords

Related Articles

TMEM4 is Highly Expressed in Plasma Cell Neoplasms and Associated with B Lymphocyte Differentiation

Aiming to identify biomarkers for plasma cell neoplasms, we analyzed gene expression profile and proteomic characteristics of mouse models of plasmacytomas along with other types of B-cell neoplasms. We found that transm...

Bilateral Choroidal Metastasis as Initial Presentation of Parotid Gland Adenoid Cystic Carcinoma

Choroidal metastasis rarely reveals a primary cancer. At this stage, they are associated with multiple metastases. Adenoid cystic carcinoma also known as cylindroma is very rare and constitutes 1% of major and minor sali...

Unique COVID/Anti-Spike Protein Immune Responses in Two Elderly Patients without COVID-19 Vaccination

Published reports continue to emerge regarding different health outcomes in patients immunized and not immunized against the SARS-CoV-2 antigen (i.e., spike protein) that were infected with the virus. Because of the vast...

Targeting Immune-Evasion Mechanisms as a Possible New Approach in the Fight against Tuberculosis

The emergence of multidrug resistant Mycobacterium tuberculosis (Mtb) strains, the difficulties in the development of new safe therapies or the production of a protective vaccine against tuberculosis make the study of th...

MHC Class 1-Related Chain A and B Ligands are Differently Expressed in Cancer Cell Lines

The MHC class I related chain A and B have been of much interest in the recent past. MHC class 1 related gene A/B (MICA/B) are ligands of the NKG2D, which is an activating receptor expressed on T and NK cells (NK cells a...

Download PDF file
  • EP ID EP743460
  • DOI -
  • Views 40
  • Downloads 0

How To Cite

El-Desouki Fouda, Mahmoud Eid, Mona Hilmy Al-Rayes, Mokhtar Ragab and Gamal Abdelghany Khalifa (2018). Atherosclerosis Biomarkers Among Egyptian Patients with Systemic Lupus Erythematosus: Population Based Study. Immunological Disorders and Immunotherapy, 3(1), -. https://europub.co.uk/articles/-A-743460